WO2002094315A3 - Myostatin immunoconjugate and its use for immunisation - Google Patents
Myostatin immunoconjugate and its use for immunisation Download PDFInfo
- Publication number
- WO2002094315A3 WO2002094315A3 PCT/US2002/021862 US0221862W WO02094315A3 WO 2002094315 A3 WO2002094315 A3 WO 2002094315A3 US 0221862 W US0221862 W US 0221862W WO 02094315 A3 WO02094315 A3 WO 02094315A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- immunisation
- myostatin immunoconjugate
- myostatin
- immunoconjugate
- avians
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02752252A EP1387695A2 (en) | 2001-01-04 | 2002-01-04 | Myostatin immunoconjugate and its use for immunisation |
CA002433644A CA2433644A1 (en) | 2001-01-04 | 2002-01-04 | Myostatin immunoconjugate and its use for immunisation |
AU2002339419A AU2002339419A1 (en) | 2001-01-04 | 2002-01-04 | Myostatin immunoconjugate and its use for immunisation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/754,826 | 2001-01-04 | ||
US09/754,826 US7037501B2 (en) | 2001-01-04 | 2001-01-04 | Myostatin immnoconjugate |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002094315A2 WO2002094315A2 (en) | 2002-11-28 |
WO2002094315A3 true WO2002094315A3 (en) | 2003-02-20 |
Family
ID=25036517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/021862 WO2002094315A2 (en) | 2001-01-04 | 2002-01-04 | Myostatin immunoconjugate and its use for immunisation |
Country Status (5)
Country | Link |
---|---|
US (2) | US7037501B2 (en) |
EP (1) | EP1387695A2 (en) |
AU (1) | AU2002339419A1 (en) |
CA (1) | CA2433644A1 (en) |
WO (1) | WO2002094315A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7037501B2 (en) * | 2001-01-04 | 2006-05-02 | Regents Of The University Of Minnesota | Myostatin immnoconjugate |
TWI329129B (en) * | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
EP1572909A4 (en) * | 2002-02-21 | 2007-06-06 | Wyeth Corp | A follistatin domain containing protein |
EP1572934A4 (en) * | 2002-02-21 | 2007-12-19 | Wyeth Corp | Follistatin domain containing proteins |
US7261893B2 (en) | 2002-10-22 | 2007-08-28 | Wyeth | Neutralizing antibodies against GDF-8 and uses therefor |
US20040223966A1 (en) * | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
CA2526669A1 (en) * | 2003-06-02 | 2004-12-16 | Wyeth | Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
JP2007535912A (en) * | 2003-12-31 | 2007-12-13 | シェーリング−プラウ・リミテッド | Neutralizing epitope-based growth-enhancing vaccine |
AR051853A1 (en) * | 2004-12-30 | 2007-02-14 | Schering Plough Ltd | VACCINE TO INCREASE GROWTH BASED ON NEUTRALIZING EPITOPES |
DK1915397T3 (en) | 2005-08-19 | 2015-04-20 | Wyeth Llc | Antagonist AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8-ASSOCIATED DISEASES |
EP1798292A1 (en) * | 2005-12-19 | 2007-06-20 | Nutreco Nederland B.V. | Methods for improving turkey meat production |
TW200800257A (en) * | 2006-06-22 | 2008-01-01 | Genereach Biotechnology Corp | Non-genetic engineering promotion growth method and its vaccine is provided |
KR102079921B1 (en) * | 2007-06-01 | 2020-02-21 | 더 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신, 인코포레이티드 | Vaccine for the prevention of breast cancer relapse |
US8321012B2 (en) * | 2009-12-22 | 2012-11-27 | The Invention Science Fund I, Llc | Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject |
WO2013186719A1 (en) | 2012-06-15 | 2013-12-19 | Pfizer Inc. | Improved antagonist antibodies against gdf-8 and uses therefor |
KR20150108405A (en) * | 2013-02-22 | 2015-09-25 | 조에티스 서비시즈 엘엘씨 | In ovo administration of growth factors for improving poultry performance |
US10400013B2 (en) | 2016-10-26 | 2019-09-03 | Chao-Wei Liao | Fusion polypeptide for immuno-enhancement and method for enhancing stimulation of immune response using the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2333706A (en) * | 1998-02-02 | 1999-08-04 | Merck & Co Inc | Method for increasing muscle mass in animals |
WO1999042573A1 (en) * | 1998-02-19 | 1999-08-26 | Biostar Inc. | Immunological methods to modulate myostatin in vertebrate subjects |
WO2001005820A2 (en) * | 1999-07-20 | 2001-01-25 | Pharmexa A/S | Method for down-regulating gdf-8 activity |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5128127A (en) | 1989-02-08 | 1992-07-07 | Stolle Research & Development Corp. | Increased protein production in animals |
US5185148A (en) | 1991-12-16 | 1993-02-09 | Mycogen Corporation | Process for controlling scarab pests with Bacillus thuringiensis isolates |
US5554534A (en) | 1991-12-16 | 1996-09-10 | Mycogen Corporation | Bacillus thuringiensis toxins active against scarab pests |
US5994618A (en) | 1997-02-05 | 1999-11-30 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 transgenic mice |
JPH09507829A (en) | 1993-03-19 | 1997-08-12 | ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | Growth differentiation factor-8 |
WO1998033887A1 (en) | 1997-02-05 | 1998-08-06 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-8 |
PT2045322E (en) | 1997-07-14 | 2015-10-16 | Université de Liège | Double-muscling in mammals |
WO1999006559A1 (en) | 1997-08-01 | 1999-02-11 | The Johns Hopkins University School Of Medicine | Methods to identify growth differentiation factor (gdf) receptors |
DE19806040A1 (en) | 1998-02-13 | 1999-09-09 | Stork Mbk Gmbh | Device and method for applying a medium to a substrate and system with several such devices |
WO2000043781A2 (en) | 1999-01-21 | 2000-07-27 | Metamorphix, Inc. | Growth differentiation factor inhibitors and uses therefor |
US7037501B2 (en) * | 2001-01-04 | 2006-05-02 | Regents Of The University Of Minnesota | Myostatin immnoconjugate |
-
2001
- 2001-01-04 US US09/754,826 patent/US7037501B2/en not_active Expired - Lifetime
-
2002
- 2002-01-04 CA CA002433644A patent/CA2433644A1/en not_active Abandoned
- 2002-01-04 EP EP02752252A patent/EP1387695A2/en not_active Withdrawn
- 2002-01-04 AU AU2002339419A patent/AU2002339419A1/en not_active Abandoned
- 2002-01-04 WO PCT/US2002/021862 patent/WO2002094315A2/en not_active Application Discontinuation
-
2005
- 2005-10-11 US US11/247,691 patent/US7488480B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2333706A (en) * | 1998-02-02 | 1999-08-04 | Merck & Co Inc | Method for increasing muscle mass in animals |
WO1999042573A1 (en) * | 1998-02-19 | 1999-08-26 | Biostar Inc. | Immunological methods to modulate myostatin in vertebrate subjects |
WO2001005820A2 (en) * | 1999-07-20 | 2001-01-25 | Pharmexa A/S | Method for down-regulating gdf-8 activity |
Non-Patent Citations (1)
Title |
---|
MCPHERRON ET AL: "Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 387, 1 May 1997 (1997-05-01), pages 83 - 90, XP002085797, ISSN: 0028-0836 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002339419A1 (en) | 2002-12-03 |
CA2433644A1 (en) | 2002-11-28 |
US20020127234A1 (en) | 2002-09-12 |
EP1387695A2 (en) | 2004-02-11 |
WO2002094315A2 (en) | 2002-11-28 |
US7037501B2 (en) | 2006-05-02 |
US20060088543A1 (en) | 2006-04-27 |
US7488480B2 (en) | 2009-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002094315A3 (en) | Myostatin immunoconjugate and its use for immunisation | |
WO2003039470A3 (en) | Polyvalent immunogen of hiv | |
AU2001252525A1 (en) | Method for production of enhanced traceable immunizing drinking water and other liquid and gas products, devices for production and use thereof, and use of the enhanced products for immunizing living beings | |
WO2001089457A3 (en) | Thrombopoietin mimetics | |
EG23254A (en) | Device and method for the generation of electricalenergy. | |
AU2002255791A1 (en) | Coupled optical and optoelectronic devices, and method of making the same | |
NO20041882L (en) | Methods for the treatment of ocular neovascular diseases. | |
WO2003045304A3 (en) | Mutable vaccines | |
WO2002092122A3 (en) | Use of osteopontin for the treatment and/or prevention of neurologic diseases | |
WO2001060347A3 (en) | Method for treating ocular pain | |
BR0106097B1 (en) | system to temporarily stop or abort a laser surgical procedure. | |
WO2002075274A3 (en) | Method and kit for following neurodegenerative diseases | |
WO2003024516A3 (en) | Catheter having increased curve performance through heat treatment | |
TWI349525B (en) | Immunization of plants against bacterioses | |
WO2004062583A3 (en) | Vaccine and method for preventing biofilm formation | |
ZA200204019B (en) | Combination treatment for alcoholism and alcohol dependence. | |
NO20034123L (en) | Procedure for the treatment of fuel | |
WO1999057278A3 (en) | IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) | |
WO2005016952A3 (en) | Polyvalent immunogen | |
GB2424848B (en) | Method of forming member, valve guide and method of forming the valve guide, and method of forming tubular member | |
EP1032583A4 (en) | Active immunization against angiogenesis-associated antigens | |
AU2002339189A8 (en) | Coating of optical device facets at the wafer-level | |
MXPA03004019A (en) | Passivation method. | |
ZA200102636B (en) | Method of treating a parasitic infection. | |
ITMI20031766A1 (en) | DEVICE AND PROCEDURE FOR THE CLOSURE OF AMPOULTS BY LASER IRRADIANCE. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2433644 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2002752252 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002752252 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002752252 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |